573 related articles for article (PubMed ID: 15673298)
1. IgA1-containing immune complexes in IgA nephropathy differentially affect proliferation of mesangial cells.
Novak J; Tomana M; Matousovic K; Brown R; Hall S; Novak L; Julian BA; Wyatt RJ; Mestecky J
Kidney Int; 2005 Feb; 67(2):504-13. PubMed ID: 15673298
[TBL] [Abstract][Full Text] [Related]
2. IgA1 immune complexes from pediatric patients with IgA nephropathy activate cultured human mesangial cells.
Novak J; Raskova Kafkova L; Suzuki H; Tomana M; Matousovic K; Brown R; Hall S; Sanders JT; Eison TM; Moldoveanu Z; Novak L; Novak Z; Mayne R; Julian BA; Mestecky J; Wyatt RJ
Nephrol Dial Transplant; 2011 Nov; 26(11):3451-7. PubMed ID: 21828345
[TBL] [Abstract][Full Text] [Related]
3. Interactions of human mesangial cells with IgA and IgA-containing immune complexes.
Novak J; Vu HL; Novak L; Julian BA; Mestecky J; Tomana M
Kidney Int; 2002 Aug; 62(2):465-75. PubMed ID: 12110007
[TBL] [Abstract][Full Text] [Related]
4. IgA nephropathy and Henoch-Schoenlein purpura nephritis: aberrant glycosylation of IgA1, formation of IgA1-containing immune complexes, and activation of mesangial cells.
Novak J; Moldoveanu Z; Renfrow MB; Yanagihara T; Suzuki H; Raska M; Hall S; Brown R; Huang WQ; Goepfert A; Kilian M; Poulsen K; Tomana M; Wyatt RJ; Julian BA; Mestecky J
Contrib Nephrol; 2007; 157():134-8. PubMed ID: 17495451
[TBL] [Abstract][Full Text] [Related]
5. Both IgA nephropathy and alcoholic cirrhosis feature abnormally glycosylated IgA1 and soluble CD89-IgA and IgG-IgA complexes: common mechanisms for distinct diseases.
Tissandié E; Morelle W; Berthelot L; Vrtovsnik F; Daugas E; Walker F; Lebrec D; Trawalé JM; Francoz C; Durand F; Moura IC; Paradis V; Moreau R; Monteiro RC
Kidney Int; 2011 Dec; 80(12):1352-63. PubMed ID: 21866091
[TBL] [Abstract][Full Text] [Related]
6. The effect of IgA immune complexes on the proliferation of cultured human mesangial cells.
Fujii K; Muller KD; Clarkson AR; Woodroffe AJ
Am J Kidney Dis; 1990 Sep; 16(3):207-10. PubMed ID: 2399913
[TBL] [Abstract][Full Text] [Related]
7. Circulating immune complexes and immunoglobulin A rheumatoid factor in patients with mesangial immunoglobulin A nephropathies.
Czerkinsky C; Koopman WJ; Jackson S; Collins JE; Crago SS; Schrohenloher RE; Julian BA; Galla JH; Mestecky J
J Clin Invest; 1986 Jun; 77(6):1931-8. PubMed ID: 3711340
[TBL] [Abstract][Full Text] [Related]
8. Aberrant glycosylation of IgA1 and anti-glycan antibodies in IgA nephropathy: role of mucosal immune system.
Novak J; Moldoveanu Z; Julian BA; Raska M; Wyatt RJ; Suzuki Y; Tomino Y; Gharavi AG; Mestecky J; Suzuki H
Adv Otorhinolaryngol; 2011; 72():60-3. PubMed ID: 21865691
[TBL] [Abstract][Full Text] [Related]
9. Sialylation of IgG inhibits the formation of galactose-deficient IgA1-containing immune complexes and protects mesangial cells from injury in IgA nephropathy.
Liu Y; Li H; Yu H; Wang F; Jia J; Yan T
BMC Nephrol; 2022 Jan; 23(1):25. PubMed ID: 35016642
[TBL] [Abstract][Full Text] [Related]
10. Binding capacity and pathophysiological effects of IgA1 from patients with IgA nephropathy on human glomerular mesangial cells.
Wang Y; Zhao MH; Zhang YK; Li XM; Wang HY
Clin Exp Immunol; 2004 Apr; 136(1):168-75. PubMed ID: 15030528
[TBL] [Abstract][Full Text] [Related]
11. Engagement of transferrin receptor by polymeric IgA1: evidence for a positive feedback loop involving increased receptor expression and mesangial cell proliferation in IgA nephropathy.
Moura IC; Arcos-Fajardo M; Gdoura A; Leroy V; Sadaka C; Mahlaoui N; Lepelletier Y; Vrtovsnik F; Haddad E; Benhamou M; Monteiro RC
J Am Soc Nephrol; 2005 Sep; 16(9):2667-76. PubMed ID: 15987753
[TBL] [Abstract][Full Text] [Related]
12. Mesangial cells from patients with IgA nephropathy have increased susceptibility to galactose-deficient IgA1.
Ebefors K; Liu P; Lassén E; Elvin J; Candemark E; Levan K; Haraldsson B; Nyström J
BMC Nephrol; 2016 Apr; 17():40. PubMed ID: 27044423
[TBL] [Abstract][Full Text] [Related]
13. Role of macromolecular IgA in IgA nephropathy.
van der Boog PJ; van Kooten C; de Fijter JW; Daha MR
Kidney Int; 2005 Mar; 67(3):813-21. PubMed ID: 15698421
[TBL] [Abstract][Full Text] [Related]
14. Pathogenic role of glycan-specific IgG antibodies in IgA nephropathy.
Zhao YF; Zhu L; Liu LJ; Shi SF; Lv JC; Zhang H
BMC Nephrol; 2017 Sep; 18(1):301. PubMed ID: 28969604
[TBL] [Abstract][Full Text] [Related]
15. Soluble CD89 is a critical factor for mesangial proliferation in childhood IgA nephropathy.
Cambier A; Gleeson PJ; Abbad L; Canesi F; da Silva J; Bex-Coudrat J; Deschênes G; Boyer O; Rabant M; Ulinski T; Hogan J; Peuchmaur M; Berthelot L; Monteiro RC
Kidney Int; 2022 Feb; 101(2):274-287. PubMed ID: 34756952
[TBL] [Abstract][Full Text] [Related]
16. Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies.
Tomana M; Novak J; Julian BA; Matousovic K; Konecny K; Mestecky J
J Clin Invest; 1999 Jul; 104(1):73-81. PubMed ID: 10393701
[TBL] [Abstract][Full Text] [Related]
17. IgA-containing immune complexes in the urine of IgA nephropathy patients.
Matousovic K; Novak J; Yanagihara T; Tomana M; Moldoveanu Z; Kulhavy R; Julian BA; Konecny K; Mestecky J
Nephrol Dial Transplant; 2006 Sep; 21(9):2478-84. PubMed ID: 16757497
[TBL] [Abstract][Full Text] [Related]
18. New insights in the pathogenesis of IgA nephropathy.
Monteiro RC
Nefrologia; 2005; 25 Suppl 2():82-6. PubMed ID: 16050408
[TBL] [Abstract][Full Text] [Related]
19. Glycosylation of circulating IgA in patients with IgA nephropathy modulates proliferation and apoptosis of mesangial cells.
Amore A; Cirina P; Conti G; Brusa P; Peruzzi L; Coppo R
J Am Soc Nephrol; 2001 Sep; 12(9):1862-1871. PubMed ID: 11518779
[TBL] [Abstract][Full Text] [Related]
20. Aberrantly glycosylated serum IgA1 are closely associated with pathologic phenotypes of IgA nephropathy.
Xu LX; Zhao MH
Kidney Int; 2005 Jul; 68(1):167-72. PubMed ID: 15954905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]